J. G. van der Schroeff

Ras Oncogene Mutations in Basal Cell Carcinomas and Squamous Cell Carcinomas of Human Skin

J. G. van der Schroeff, Ludo M. Evers, Johannes L. Bos · Journal of Investigative Dermatology · 1990 · 181 citations

Medicine, Genetics, Molecular Genetics +17

A randomized treatment duration-finding study of terbinafine in onychomycosis

J. G. van der Schroeff, P.K.S. CIRKEL, Marianne B. Crijns et al. · British Journal of Dermatology · 1992 · 171 citations

Medicine, Dermatology, Pharmacology +17

Fumaric acid therapy for psoriasis: A randomized, double-blind, placebo-controlled study

W.M. Nugteren‐Huying, J. G. van der Schroeff, J Hermans et al. · Journal of the American Academy of Dermatology · 1990 · 99 citations

Medicine, Dermatology, Pharmacotherapy +5

The missense mutation G12D in connexin30.3 can cause both erythrokeratodermia variabilis of Mendes da Costa and progressive symmetric erythrokeratodermia of Gottron

Maurice A. M. Van Steensel, A.P. Oranje, J. G. van der Schroeff et al. · American Journal of Medical Genetics Part A · 2009 · 66 citations

Life Sciences, Genetics, Molecular Genetics +13

Expression of EGF receptor, involucrin, and cytokeratins in basal cell carcinomas and squamous cell, carcinomas of the skin

A.P.M. Lavrijsen, L. M. Tieben, Maria Ponec et al. · Archives of Dermatological Research · 1989 · 61 citations

Medicine, Dermatology, Oncology +15